Хайлтын үр дүнгүүд - Andrzej Jakubowiak

Үр дүнг сайжруулах
  1. 1
    Evolution of carfilzomib dose and schedule in patients with multiple myeloma: A historical overview

    Evolution of carfilzomib dose and schedule in patients with multiple myeloma: A historical overview -н Andrzej Jakubowiak

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Differential Effects of Gonadotropin-Releasing Hormone (GnRH) Pulse Frequency on Gonadotropin Subunit and GnRH Receptor Messenger Ribonucleic Acid Levels in Vitro*

    Differential Effects of Gonadotropin-Releasing Hormone (GnRH) Pulse Frequency on Gonadotropin Subunit and GnRH Receptor Messenger Ribonucleic Acid Levels in Vitro* -н Ursula B. Kaiser, Andrzej Jakubowiak, Anna Steinberger, William W. Chin

    Хэвлэсэн 1997
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Monoclonal antibodies in the treatment of multiple myeloma

    Monoclonal antibodies in the treatment of multiple myeloma -н Paul G. Richardson, Sagar Lonial, Andrzej Jakubowiak, Jean‐Luc Harousseau, Kenneth C. Anderson

    Хэвлэсэн 2011
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma

    Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma -н Ola Landgren, Pieter Sonneveld, Andrzej Jakubowiak, Mohamad Mohty, Karim Iskander, Khalid Mezzi, David S. Siegel

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis

    Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis -н Benjamin A. Derman, Jagoda Jasielec, Spencer S. Langerman, Wei Zhang, Andrzej Jakubowiak, Brian C.‐H. Chiu

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation

    Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous ste... -н Benjamin A. Derman, Andrew Stefka, Ken Jiang, Amanda McIver, Tadeusz Kubicki, Jagoda Jasielec, Andrzej Jakubowiak

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia

    Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia -н Lisa Kujawski, Peter Ouillette, Harry P. Erba, Chris Saddler, Andrzej Jakubowiak, Mark Kaminski, Kerby Shedden, Sami N. Malek

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective

    Cost-effectiveness of adding carfilzomib to lenalidomide and dexamethasone in relapsed multiple myeloma from a US perspective -н Andrzej Jakubowiak, Marco Campioni, Ágnes Benedict, Ivan Houisse, Eszter Tichy, Andromachi Giannopoulou, Sanjay Aggarwal, Beth Barber, Sumeet Panjabi

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)

    Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) -н Benjamin A. Derman, Ajay Major, Jennifer H. Cooperrider, Ken Jiang, Aubrianna Ramsland, Theodore Karrison, Tadeusz Kubicki, Andrzej Jakubowiak

    Хэвлэсэн 2024
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma

    Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma -н Andrzej Jakubowiak, Don M. Benson, William Bensinger, David S. Siegel, Todd M. Zimmerman, Ann Mohrbacher, Paul G. Richardson, Daniel Afar, Anil Singhal, Kenneth C. Anderson

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia

    A Phase Ib/II Study of Oprozomib in Patients with Advanced Multiple Myeloma and Waldenström Macroglobulinemia -н Irene M. Ghobrial, Ravi Vij, David S. Siegel, Ashraf Badros, Jonathan L. Kaufman, Noopur Raje, Andrzej Jakubowiak, Michael R. Savona, Mihaela Obreja, Jesús G. Berdeja

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition

    Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition -н Mikhail A. Nikiforov, MaryBeth Riblett, W. H. Wilson Tang, Vladimir Gratchouck, Dazhong Zhuang, Yolanda Fernández, Monique Verhaegen, Sooryanarayana Varambally, Arul M. Chinnaiyan, Andrzej Jakubowiak, Marı́a S. Soengas

    Хэвлэсэн 2007
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant

    Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant -н Benjamin A. Derman, Jennifer H. Cooperrider, Jacalyn Rosenblatt, David Avigan, Murtuza Rampurwala, David R. Barnidge, Ajay Major, Theodore Karrison, Ken Jiang, Aubrianna Ramsland, Tadeusz Kubicki, Andrzej Jakubowiak

    Хэвлэсэн 2024
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma

    Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma -н Andrzej Jakubowiak, Shaji Kumar, Rohan Medhekar, Huiling Pei, Patrick Lefèbvre, Shuchita Kaila, Jianming He, Marie‐Hélène Lafeuille, Annelore Cortoos, Anil Londhe, Panagiotis Mavros, Thomas S. Lin, Saad Z. Usmani

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

    Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with... -н Noopur Raje, Andrzej Jakubowiak, Cristina Gasparetto, Robert F. Cornell, Heike I. Krupka, Daniel Navarro, Alison Forgie, Chandrasekhar Udata, Cynthia Basu, Jeffrey Chou, Abraham C.F. Leung, Alexander M. Lesokhin

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    An open‐label, single‐arm, phase 2 study of single‐agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib

    An open‐label, single‐arm, phase 2 study of single‐agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib... -н Ravi Vij, David S. Siegel, Sundar Jagannath, Andrzej Jakubowiak, Alexander K. Stewart, Kevin T. McDonagh, Nizar J. Bahlis, Andrew R. Belch, Lori Kunkel, Sandra Wear, Alvin Wong, Robert Z. Orlowski, Michael Wang

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma

    Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma -н Sagar Lonial, Paul G. Richardson, Jesús F. San Miguel, Pieter Sonneveld, Michael W. Schuster, Joan Bladé, Jamie Cavenagh, S. Vincent Rajkumar, Andrzej Jakubowiak, Dixie‐Lee Esseltine, Kenneth C. Anderson, Jean‐Luc Harousseau

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor

    Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10–Dependent Apoptosis by Carfilzomib and Selinexor -н Shaun Rosebeck, Mattina M. Alonge, Malathi Kandarpa, Anoop Mayampurath, Samuel L. Volchenboum, Jagoda Jasielec, Dominik Dytfeld, Sean P. Maxwell, Stephanie J. Kraftson, Dilara McCauley, Sharon Shacham, Michael Kauffman, Andrzej Jakubowiak

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study

    Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study -н Jonathan L. Kaufman, Roberto Mina, Andrzej Jakubowiak, Todd L. Zimmerman, Jeffrey Wolf, Colleen Lewis, Charise Gleason, Cathy Sharp, Thomas G Martin, Leonard T. Heffner, Ajay K. Nooka, R. Donald Harvey, Sagar Lonial

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1

    Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1 -н Paul G. Richardson, Todd M. Zimmerman, Craig C. Hofmeister, Moshe Talpaz, Asher Chanan‐Khan, Jonathan L. Kaufman, Jacob P. Laubach, Dharminder Chauhan, Andrzej Jakubowiak, Steven D. Reich, Mohit Trikha, Kenneth C. Anderson

    Хэвлэсэн 2016
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: